Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Makio Shozu

Showing results (81-90 of 193) with videos related to

Pageof 20
Sort By:
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|December 12, 2024
Anti-Centromere Protein A Antibody Disrupts the Competence of Mouse Oocytes Matured In VitroMasashi Shioya, Keiichi Takahashi, Shun Nakano, et al.
BMJ Open|March 2, 2020
Medroxyprogesterone acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and endometrial carcinoma: trial protocol for a prospective, randomised, open, blinded-endpoint design, dose-response trial (FELICIA trial)Akira Mitsuhashi, Yohei Kawasaki, Makoto Hori, et al.
BMC Pregnancy and Childbirth|December 15, 2023
Metroplasty increases the take-home baby rate by reducing pregnancy loss without changing the chance of conception in women with septate uterus: a retrospective, single-center, observational studyAkiko Omoto, Hiroshi Ishikawa, Mariko Inoue, et al.
Cancer Diagnosis & Prognosis|March 4, 2024
Removal of an Intrauterine Polypoid Lesion Resolved Chemotherapy-resistant Gestational Trophoblastic Neoplasia: A Case ReportAsuka Sato, Hirokazu Usui, Natsuko Nakamura, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 19, 2003
The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promotersSerdar E Bulun, Siby Sebastian, Kazuto Takayama, et al.
Gynecologic Oncology Reports|January 1, 2020
Development of localized cul-de-sac endometrioid carcinoma associated with deep infiltrating endometriosis during remission of early endometrial cancerKumiko Seki, Hiroshi Ishikawa, Rei Hashimoto, et al.
Journal of Gynecologic Oncology|November 13, 2020
Tailored-dose chemotherapy with gemcitabine and irinotecan in patients with platinum-refractory/resistant ovarian or primary peritoneal cancer: a phase II trialShinichi Tate, Kyoko Nishikimi, Ayumu Matsuoka, et al.
Journal of Gynecologic Oncology|January 9, 2020
Microscopic diseases remain in initial disseminated sites after neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and primary peritoneal cancerShinichi Tate, Kyoko Nishikimi, Kazuyoshi Kato, et al.
Journal of Gynecologic Oncology|October 3, 2019
Long-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patientsAkira Mitsuhashi, Yuji Habu, Tatsuya Kobayashi, et al.
Breast Cancer (Tokyo, Japan)|April 30, 2013
Lack of genomic rearrangements involving the aromatase gene CYP19A1 in breast cancerMaki Fukami, Junichi Suzuki, Kazuhiko Nakabayashi, et al.
Pageof 20

Showing results (81-90 of 193) with videos related to

Sort By:
Pageof 20
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|December 12, 2024
Anti-Centromere Protein A Antibody Disrupts the Competence of Mouse Oocytes Matured In VitroMasashi Shioya, Keiichi Takahashi, Shun Nakano, et al.
BMJ Open|March 2, 2020
Medroxyprogesterone acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and endometrial carcinoma: trial protocol for a prospective, randomised, open, blinded-endpoint design, dose-response trial (FELICIA trial)Akira Mitsuhashi, Yohei Kawasaki, Makoto Hori, et al.
BMC Pregnancy and Childbirth|December 15, 2023
Metroplasty increases the take-home baby rate by reducing pregnancy loss without changing the chance of conception in women with septate uterus: a retrospective, single-center, observational studyAkiko Omoto, Hiroshi Ishikawa, Mariko Inoue, et al.
Cancer Diagnosis & Prognosis|March 4, 2024
Removal of an Intrauterine Polypoid Lesion Resolved Chemotherapy-resistant Gestational Trophoblastic Neoplasia: A Case ReportAsuka Sato, Hirokazu Usui, Natsuko Nakamura, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 19, 2003
The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promotersSerdar E Bulun, Siby Sebastian, Kazuto Takayama, et al.
Gynecologic Oncology Reports|January 1, 2020
Development of localized cul-de-sac endometrioid carcinoma associated with deep infiltrating endometriosis during remission of early endometrial cancerKumiko Seki, Hiroshi Ishikawa, Rei Hashimoto, et al.
Journal of Gynecologic Oncology|November 13, 2020
Tailored-dose chemotherapy with gemcitabine and irinotecan in patients with platinum-refractory/resistant ovarian or primary peritoneal cancer: a phase II trialShinichi Tate, Kyoko Nishikimi, Ayumu Matsuoka, et al.
Journal of Gynecologic Oncology|January 9, 2020
Microscopic diseases remain in initial disseminated sites after neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and primary peritoneal cancerShinichi Tate, Kyoko Nishikimi, Kazuyoshi Kato, et al.
Journal of Gynecologic Oncology|October 3, 2019
Long-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patientsAkira Mitsuhashi, Yuji Habu, Tatsuya Kobayashi, et al.
Breast Cancer (Tokyo, Japan)|April 30, 2013
Lack of genomic rearrangements involving the aromatase gene CYP19A1 in breast cancerMaki Fukami, Junichi Suzuki, Kazuhiko Nakabayashi, et al.
Pageof 20